Response to Comments: Skin Substitute Grafts/Cellular and/or Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers

This document (A59517) contains summaries of public comments and contractor responses related to Novitas LCD DL35041 on skin substitute grafts/cellular and tissue-based products for diabetic foot ulcers and venous leg ulcers, and does not itself present explicit coverage criteria. For actionable indications, limitations, required documentation, and frequency limits, review the final LCD DL35041; manual review of that LCD is required to extract structured policy criteria.

"This document is a response-to-comments accompanying LCD DL35041 and does not itself list specific coverage criteria; refer to Novitas LCD DL35041 (Skin Substitute Grafts/Cellular and/or Tissue-Bas..."

Sign up to see full coverage criteria, indications, and limitations.